Results 41 to 50 of about 885,184 (197)

Local Drug Delivery for Prevention of Hearing Loss

open access: yesFrontiers in Cellular Neuroscience, 2019
Systemic delivery of therapeutics for targeting the cochlea to prevent or treat hearing loss is challenging. Systemic drugs have to cross the blood-labyrinth barrier (BLB).
Leonard P. Rybak   +4 more
doaj   +1 more source

Deformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery. [PDF]

open access: yes, 2017
Phospholipid-based deformable nanovesicles (DNVs) that have flexibility in shape offer an adaptable and facile method to encapsulate diverse classes of therapeutics and facilitate localized transdermal delivery while minimizing systemic exposure. Here we
Alam, Mohammad Parvez   +7 more
core   +2 more sources

Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements

open access: yesPharmaceutics, 2020
Colon targeted drug delivery systems have gained a great deal of attention as potential carriers for the local treatment of colonic diseases with reduced systemic side effects and also for the enhanced oral delivery of various therapeutics vulnerable to ...
Sang Hoon Lee   +5 more
doaj   +1 more source

Vascular Regeneration by Local Growth Factor Release Is Self-Limited by Microvascular Clearance [PDF]

open access: yes, 2008
Background— The challenge of angiogenesis science is that stable sustained vascular regeneration in humans has not been realized despite promising preclinical findings.
Edelman, Elazer R.   +5 more
core   +1 more source

Prevention of Restenosis by Local Drug Delivery

open access: yesJournal of Cardiovascular Pharmacology and Therapeutics, 1996
Local drug therapy for preventing restenosis after angioplasty has been investigated for over a decade. Biologically active agents ranging from drugs to genes can be delivered locally using a wide variety of catheters. Microspheres, liposomes, and polymers have been used to enhance drug retention at the delivery site.
, Makkar   +3 more
openaire   +2 more sources

The potential of silk and silk-like proteins as natural mucoadhesive biopolymers for controlled drug delivery

open access: yesFrontiers in Chemistry, 2015
Drug delivery across mucus membranes is a particularly effective route of administration due to the large surface area. However, the unique environment present at the mucosa necessitates altered drug formulations designed to (1) deliver sensitive ...
Amanda E Brooks
doaj   +1 more source

Advances in oral transmucosal drug delivery [PDF]

open access: yes, 2011
Original article can be found at : http://sciencedirect.com/ Copyright ElsevierThe successful delivery of drugs across the oral mucosa represents a continuing challenge, as well as a great opportunity.
Brown, Marc   +2 more
core   +1 more source

Investigation of particle accumulation, chemosensitivity and thermosensitivity for effective solid tumor therapy using thermosensitive liposomes and hyperthermia [PDF]

open access: yes, 2016
Doxorubicin (Dox) loaded thermosensitive liposomes (TSLs) have shown promising results for hyperthermia-induced local drug delivery to solid tumors. Typically, the tumor is heated to hyperthermic temperatures (41-42 °C), which induced intravascular drug ...
Bolkestein, M. (Michiel)   +6 more
core   +3 more sources

Microtransformers: controlled microscale navigation with flexible robots [PDF]

open access: yes, 2018
Artificial microswimmers are a new technology with promising microfluidics and biomedical applications, such as directed cargo transport, microscale assembly, and targeted drug delivery. A fundamental barrier to realising this potential is the ability to
Montenegro-Johnson, Thomas D.
core   +2 more sources

Cascade-targeted delivery platform enhances antigen cross-presentation and STING activation for durable cellular immunity

open access: yesBioactive Materials
Achieving robust and durable cellular immunity remains a key challenge in the development of subunit vaccines, primarily due to inefficient antigen cross-presentation and inadequate immune activation.
Yuan Xue   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy